The aim of the study was to evaluate arterial stiffness and its modulating factors measured by carotid-femoral pulse wave velocity (PWV) and central augmentation index (AI) in patients with pheochromocytoma (PHEO) before and after surgery. Forty-five patients with PHEO and 45 healthy controls were investigated using an applanation tonometer (SphygmoCor, AtCor Medical). The gender, age, BMI and lipid profiles were comparable among both groups. The main difference in basic characteristic was as expected for fasting plasma glucose (P<0.001) and all blood pressure modalities. PWV in PHEO was significantly higher than in controls (7.2+/-1.4 vs. 5.8+/-0.5 ms(-1); P<0.001). Between-group difference in PWV remained significant even after the adjustment for age, heart rate, fasting plasma glucose and each of brachial (P<0.001) and 24 h blood pressure parameters (P<0.01). The difference in AI between groups did not reach the statistical significance (19+/-14 vs. 16+/-13%; NS). In multiple regression analysis, age (P<0.001), mean blood pressure (P=0.002), high-sensitive C-reactive protein (hs-CRP) (P=0.007) and 24 h urine norepinephrine (P=0.007) were independently associated with PWV in PHEO. In addition, 27 patients with PHEO were studied 1 year after tumor removal. Successful tumor removal led to a significant decrease in PWV (7.0+/-1.2 vs. 6.0+/-1.1 ms(-1); P<0.001). In conclusion, patients with PHEO have an increase in PWV, which is reversed by the successful tumor removal. Age, mean blood pressure, hs-CRP and norepinephrine levels are independent predictors of PWV.

3rd Department of Medicine General Faculty Hospital 1st Medical Faculty Charles University Prague Prague 2 Czech Republic

Zobrazit více v PubMed

Porteri E, Rizzoni D, Mulvany MJ, De Ciuceis C, Sleiman I, Boari GE, Castellano M, Muiesan ML, Zani F, Rosei EA. Adrenergic mechanisms and remodeling of subcutaneous small resistance arteries in humans. Journal of Hypertension. 2003;21:2345–2352. PubMed

Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension. 1999;34:724–728. PubMed

O’Callaghan CJ, Williams B. The regulation of human vascular smooth muscle extracellular matrix protein production by alpha- and beta-adrenoceptor stimulation. Journal of Hypertension. 2002;20:287–294. PubMed

Ward MR, Pasterkamp G, Yeung AC, Borst C. Arterial remodeling. Mechanisms and clinical implications. Circulation. 2000;102:1186–1191. PubMed

Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39:10–15. PubMed

Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33:1111–1117. PubMed

Amar J, Ruidavets JB, Chamontin B, Drouet L, Ferrieres J. Arterial stiffness and cardiovascular risk factors in a population-based study. Journal of Hypertension. 2001;19:381–387. PubMed

Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–1241. PubMed

Laurent S, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B, Boutouyrie P. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003;34:1203–1206. PubMed

Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006;113:664–670. PubMed

Shokawa T, Imazu M, Yamamoto H, Toyofuku M, Tasaki N, Okimoto T, Yamane K, Kohno N. Pulse wave velocity predicts cardiovascular mortality: findings from the Hawaii-Los Angeles-Hiroshima study. Circ J. 2005;69:259–264. PubMed

O’Rourke M. Mechanical principles in arterial disease. Hypertension. 1995;26:2–9. PubMed

Schram MT, Henry RM, van Dijk RA, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Westerhof N, Stehouwer CD. Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension. 2004;43:176–181. PubMed

Blacher J, Safar ME, Pannier B, Guerin AP, Marchais SJ, London GM. Prognostic significance of arterial stiffness measurements in end-stage renal disease patients. Current Opinion in Nephrology and Hypertension. 2002;11:629–634. PubMed

Virdis A, Ghiadoni L, Plantinga Y, Taddei S, Salvetti A. C-reactive protein and hypertension: is there a causal relationship? Curr Pharm Des. 2007;13:1693–1698. PubMed

Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005;366:665–675. PubMed

Zelinka T, Eisenhofer G, Pacak K. Pheochromocytoma as a catecholamine producing tumor: Implications for clinical practice. Stress. 2007;10:195–203. PubMed

Widimský J., Jr Recent advances in the diagnosis and treatment of pheochromocytoma. Kidney Blood Press Res. 2006;29:321–326. PubMed

Holaj R, Zelinka T, Wichterle D, Petrak O, Strauch B, Vrankova A, Majtan B, Spacil J, Malik J, Widimsky J., Jr Increased carotid intima-media thickness in patients with pheochromocytoma in comparison to essential hypertension. Journal of Human Hypertension. 2009;23:350–8. PubMed

Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med. 2006;23:579–593. PubMed

O’Rourke MF, Pauca A, Jiang XJ. Pulse wave analysis. British Journal of Clinical Pharmacology. 2001;51:507–522. PubMed PMC

Filipovský J, Svobodová V, Pecen L. Reproducibility of radial pulse wave analysis in healthy subjects. Journal of Hypertension. 2000;18:1033–1040. PubMed

Faber JE, Yang N, Xin X. Expression of alpha-adrenoceptor subtypes by smooth muscle cells and adventitial fibroblasts in rat aorta and in cell culture. The Journal of Pharmacology and Experimental Therapeutics. 2001;298:441–452. PubMed

Head RJ. Hypernoradrenergic innervation and vascular smooth muscle hyperplastic change. Blood Vessels. 1991;28:173–178. PubMed

Johnson MD, Grignolo A, Kuhn CM, Schanberg SM. Hypertension and cardiovascular hypertrophy during chronic catecholamine infusion in rats. Life Sciences. 1983;33:169–180. PubMed

Jonsson JR, Head RJ, Frewin DB. Effect of alpha 1-adrenoceptor blockade on the development of hypertension in the spontaneously hypertensive rat. European Journal of Pharmacology. 1992;211:263–268. PubMed

Zhang H, Faber JE. Trophic effect of norepinephrine on arterial intima-media and adventitia is augmented by injury and mediated by different alpha1-adrenoceptor subtypes. Circulation Research. 2001;89:815–822. PubMed

Dinenno FA, Jones PP, Seals DR, Tanaka H. Age-associated arterial wall thickening is related to elevations in sympathetic activity in healthy humans. Am J Physiol Heart Circ Physiol. 2000;278:H1205–1210. PubMed

Grassi G. Role of the sympathetic nervous system in human hypertension. Journal of Hypertension. 1998;16:1979–1987. PubMed

Grassi G, Seravalle G, Turri C, Mancia G. Sympathetic nerve traffic responses to surgical removal of pheochromocytoma. Hypertension. 1999;34:461–465. PubMed

Turnbull DM, Johnston DG, Alberti KG, Hall R. Hormonal and metabolic studies in a patient with a pheochromocytoma. The Journal of Clinical Endocrinology and Metabolism. 1980;51:930–933. PubMed

Henry RM, Kostense PJ, Spijkerman AM, Dekker JM, Nijpels G, Heine RJ, Kamp O, Westerhof N, Bouter LM, Stehouwer CD. Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation. 2003;107:2089–2095. PubMed

Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia. 2001;44:129–146. PubMed

Zelinka T, Strauch B, Petrak O, Holaj R, Vrankova A, Weisserova H, Pacak K, Widimsky J., Jr Increased blood pressure variability in pheochromocytoma compared to essential hypertension patients. Journal of Hypertension. 2005;23:2033–2039. PubMed

Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Hayashi M. Ambulatory blood pressure variability and brachial-ankle pulse wave velocity in untreated hypertensive patients. Journal of Human Hypertension. 2006;20:529–536. PubMed

Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension. 2005;46:1118–1122. PubMed

Roman MJ, Devereux RB, Schwartz JE, Lockshin MD, Paget SA, Davis A, Crow MK, Sammaritano L, Levine DM, Shankar BA, Moeller E, Salmon JE. Arterial stiffness in chronic inflammatory diseases. Hypertension. 2005;46:194–199. PubMed

Zelinka T, Petrák O, Štrauch B, Holaj R, Kvasnička J, Mazoch J, Pacák K, Widimský J., Jr Elevated Inflammation Markers in Pheochromocytoma Compared to Other Forms of Hypertension. Neuroimmunomodulation. 2007;14:57–64. PubMed

Pacak K, Lenders JWM, Eisenhofer G. Pheochromocytoma : diagnosis, localization, and treatment. Blackwell; Oxford: 2007. p. 172.

Kelly RP, Millasseau SC, Ritter JM, Chowienczyk PJ. Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension. 2001;37:1429–1433. PubMed

Yasmin, Brown MJ. Similarities and differences between augmentation index and pulse wave velocity in the assessment of arterial stiffness. Qjm. 1999;92:595–600. PubMed

Schiffrin EL. Vascular stiffening and arterial compliance. Implications for systolic blood pressure. Am J Hypertens. 2004;17:39S–48S. PubMed